NCT02828787

Brief Summary

The main objective of this study is to identify by functional and structural MRI which are the brain areas activated in various pruritic situations to deduct a model describing the different causes of pruritus. The investigators are going to compare two chronic pruritus conditions (histaminergic urticaria and non histaminergic: psoriasis) to a healthy control group. The secondary objective of this study is to specify a classification index from the physiological results obtained by brain imaging to differentiate multiple types of pruritus.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 12, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

January 16, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

November 5, 2020

Status Verified

November 1, 2020

Enrollment Period

1.4 years

First QC Date

July 7, 2016

Last Update Submit

November 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • brain areas activated during a mentally induced pruritus in 3 different populations

    The primary endpoint is to highlight fMRI brain areas activated during a mentally induced pruritus in 3 different populations: healthy subjects (no pre-existing pruritus), patients with chronic urticaria (pruritus related to histaminergic pathway), and psoriasis patients (activation pathway pruritus probably PAR2-ergic but to be confirmed by the study).

    1 year

Secondary Outcomes (1)

  • index, form the combination the better able to explain the membership of an individual (individual analysis) to a pathological community or not.

    1 year

Study Arms (3)

Urticaria

EXPERIMENTAL

15 patients with urticaria

Other: MRI

Psoriasis

EXPERIMENTAL

15 patients with psoriasis

Other: MRI

healthy

OTHER

15 healthy control subjects

Other: MRI

Interventions

MRIOTHER

The study will take place in two phases. The first phase consists of a meeting of inclusion. During this phase, the principal investigator of the study will verify the inclusion criteria for patients using a questionnaire and an interview. Then, the effects of video on each person will be tested to verify that they well induce itch and measure it using visual analogue scales. This phase will also test the benefit of the relief by scraping and cold. The second phase will be carried out only if the mental induction of pruritus has been possible in the first session. It involves acquiring the corresponding physiological signals fMRI. It will also be achieved during this phase an anatomical image of the brain of each participant and an image in DTI. The phases will be carried out in this order in each participant. They will be separated at least one night.

PsoriasisUrticariahealthy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Or patient affected by psoriasis presenting a pruritus of more than 6 weeks
  • Or patient affected by urticaria presenting a pruritus of more than 6 weeks
  • Or subject without dermatosis and not presenting chronic pruritus.
  • Major
  • Able to provide written informed consent
  • Affiliated to the Social Security

You may not qualify if:

  • In connection with the award of an MRI namely:
  • The presence of implanted medical equipment susceptible to the magnetic field of MRI,
  • Claustrophobia
  • Medication, treatment and / or substances that could alter or modify brain function
  • Pregnancy
  • In connection with the mode of presentation of stimuli (video):
  • \- An uncorrected visual disorder not allowing to view videos
  • In connection with the administrative regulations:
  • Persons under 18
  • Major Persons subject to legal protection (backup justice, trusteeship, guardianship), persons deprived of liberty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Laurent MISERY

Brest, 29200, France

Location

CHRU de Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Pruritus

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesSkin ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2016

First Posted

July 12, 2016

Study Start

January 16, 2017

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

November 5, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations